Transplantation of Autologous Peripheral Blood Progenitor Cells: Impact of CD34-Cell Selection on Immunological Reconstitution

References

• Philip T., Guglielmi C., Hagenbeek A., Somers R., van der Lelie H., Bron D., Sonneveld P., Gisselbrecht C., Cahn J. Y., Harousseau J. L., Coiffier B., Biron P., Mandelli F., Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545
   PubMed Web of Science ®Google Scholar
• Attal M., Harousseau J. L., Stoppa A. M., Sotto J. J., Fuzibet J. G., Rossi J. F., Casassus P., Maisonneuve H., Facon T., Ifrah N., Payen C., Batailler R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97
   PubMed Web of Science ®Google Scholar
• Pierelli L., Menichella G., Scambia G., Iacone A., Olivieri A., Sica S., De Rosa L., Maiolino I., Mancuso S., Leone G. Growth factor administration following autologous peripheral blood progenitor cell transplantation. Leukemia Lymphoma 1997; 27: 65–75
   PubMed Web of Science ®Google Scholar
• Rutella S., Rumi C., Laurenti L., Pierelli L., Sorà F., Sica S., Leone G. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105–115
   PubMed Web of Science ®Google Scholar
• Laurenti L., Sica S., Sorà F., Piccirillo N., Ortu La, Barbera E., Chiusolo P., Salutari P., Rumi C., Rutella S., Leone G. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study. Haematologica 1999; 84: 1100–1103
   PubMed Web of Science ®Google Scholar
• Rutella S., Pierelli L., Rumi C., Bonanno G., Marone M., Sica S., Capoluongo E., Ameglio F., Scambia G., Leone G. T-cell apoptosis induced by granulocyte colony-stimulating factor (G-CSF) is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp Hematol 2001, in press
   Google Scholar
• Domonech J., Roingeard F., Binet C. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leukemia Lymphoma 1997; 24: 239–256
   PubMed Web of Science ®Google Scholar
• Talmadge J. E., Reed E., Ino K., Kessinger A., Kuszynski C., Heimann D., Varney M., Jackson J., Vose J. M., Bierman RJ. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161–172
   PubMed Web of Science ®Google Scholar
• Guillaume T., Rubinstein D. B., Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471–1490
   PubMed Web of Science ®Google Scholar
• Weaver C. H., Longin K., Buckner C. D., Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994; 13: 411–415
   PubMed Web of Science ®Google Scholar
• Richel D. J., Johnsen H. E., Canon J., Guillaume T., Schaafsma M. R., Schenkeveld C., Hansen S. W., McNiece I., Gringeri A. J., Briddell R., Ewen C., Davies R., Freeman J., Miltenyi S., Symann M. Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant 2000; 25: 243–249
   PubMed Web of Science ®Google Scholar
• Morineau N., Tang X. W., Moreau P., Milpied N., Mane B., Bataille R., Harousseau J. L. Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single-center study. Leukemia 2000; 14: 1815–1820
   PubMed Web of Science ®Google Scholar
• Dreger P., Vie H., Mann K., Von Neuhoff N., Glaubitz T., Petzoldt O., Glass B., Uharek L., Rautenberg P., Suttorp M., Mills B., Mitsky P., Schmitz N. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery. Bone Marrow Transplant 1999; 24: 153–161
   PubMed Web of Science ®Google Scholar
• Michallet M., Philip T., Philip I., Godinot H., Sebban C., Salles G., Thiebaut A., Biron P., Lopez F., Mazars P., Roubi N., Leemhuis T., Hanania E., Reading C., Fine G., Atkinson K., Juttner C., Coiffier B., Fiere D., Archimbaud E. Transplantation with selected autologous peripheral blood CD34+Thyl+ hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol 2000; 28: 858–870
   PubMed Web of Science ®Google Scholar
• Goldman J. M., Gale R. P., Horowitz M. M., Biggs J. C., Champlin R. E., Gluckman E., Hoffman R. G., Jacobsen S. J., Marmont A. M., McGlave P. B., Messner H. A., Rimm A. A., Rozman C., Speck B., Tura S., Weiner R. S., Bortin M. M. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T cell depletion. Ann Int Med 1988; 104: 619–631
   Google Scholar
• Leino L., Lilius E. M., Nikoskelainen J., Pelliniemi T. T., Rajamaki A. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1991; 8: 339–344
   PubMed Web of Science ®Google Scholar
• Parkman R., Weinberg K. I. Immunological reconstitution following hematopoietic stem cell transplantation. Hematopoietic stem cell transplantation, E. D. Thomas, K. G. Blume, S. J. Forman. Blackwell Science, Inc., Maiden(USA) 1999; 704–711
   Google Scholar
• Scheid C., Pettengell R., Ghielmini M., Radford J. A., Morgenstern G. R., Stern P. L., Crowther D. Time-course of the recovery of cellular immune function after high-dosechemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1995; 15: 901–906
   PubMed Web of Science ®Google Scholar
• Dumont-Girard F., Roux E., van Lier R. A., Hale G., Helg C., Chapuis B., Starobinski M., Roosnek E. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998; 92: 4464–4471
   PubMed Web of Science ®Google Scholar
• Roux E., Dumont-Girard F., Starobinski M., Siegrist C. A., Helg C., Chapuis B., Roosnek E. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299–2303
   PubMed Web of Science ®Google Scholar
• Mackall C. L., Hakim F. T., Gress R. E. T-cell regeneration: all repertoires are not created equal. Imm Today 1997; 18: 245–251
   PubMedGoogle Scholar
• Douek D. C., Vescio R. A., Betts M. R., Brenchley J. M., Hill B. J., Zhang L., Berenson J. R., Collins R. H., Koup R. A. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T cell reconstitution. The Lancet 2000; 355: 1875–1881
   PubMed Web of Science ®Google Scholar
• Douek D. C., McFarland R. D., Reiser P. H., Gage E. A., Massey J. M., Haynes B. F., Plois M. A., Haase A. T., Feinberg M. B., Sullivan J. L., Jamieson B. D., Zack J. A., Picker L. J., Koup R. A. Changes in thymic function with age and during the treatment of HIV infection. The Lancet 1998; 396: 690–695
   Google Scholar
• Koehne G., Zeller W., Stockschlaeder M., Zander A. R. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 149–156
   PubMed Web of Science ®Google Scholar
• Galy A., Rudraraju S., Baynes R., Klein J. Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplant 2000; 25: 1249–1255
   PubMed Web of Science ®Google Scholar
• Avigan D., Wu Z., Joyce R., Elias A., Richardson P., McDermott D., Levine J., Kennedy L., Giallombardo N., Hurley D., Gong J., Kufe D. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone Marrow Transplant 2000; 26: 169–176
   PubMed Web of Science ®Google Scholar
• Arpinati M., Green C. L., Heimfeld S., Heuser J. E., Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484–2490
   PubMed Web of Science ®Google Scholar
• Testa U., Martucci R., Rutella S., Scambia G., Sica S., Benedetti-Panici P. L., Pierelli L., Menichella G., Leone G., Mancuso S., Peschle C. Autologous stem cell transplantation: release of early-and late-acting growth factors relates with hematopoietic ablation and recovery. Blood 1994; 84: 3532–3539
   PubMed Web of Science ®Google Scholar
• Guillaume T., Sekhavat M., Rubinstein D. B., Hamdan O., Leblanc P., Symann M. L. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematological malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800–3807
   PubMed Web of Science ®Google Scholar
• Katsura K., Nomura S., Ohtani T., Matsumoto N., Shimizu T., Yamagushi K., Kishimoto Y., Kitajima H., Fukuhara S. Changes of immunological markers after autologous peripheral blood stem cell transplantation. J Cancer Res Clin Oncol 1998; 124: 633–640
   PubMed Web of Science ®Google Scholar
• Singh R. K., Ino K., Varney M. L., Heimann D. G., Talmadge J. E. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products. Bone Marrow Transplant 1999; 23: 53–62
   PubMed Web of Science ®Google Scholar
• Singh R. K., Varney M. L., Ino K., Vose J. M., Bierman P. J., Talmadge J. E. Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients. Exp Hematol 2000; 28: 499–507
   PubMed Web of Science ®Google Scholar
• Talmadge J. E., Reed E. C., Kessinger A., Kuszynski C. A., Perry G. A., Gordy C. L., Mills K. C., Thomas M. L., Pirruccello S. J., Letheby B. A., Arneson M. A., Jackson J. D. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101–109
   PubMed Web of Science ®Google Scholar
• Rutella S., Rumi C., Pierelli L., Morosetti R., Bonanno G., Sica S., Scambia G., Leone G. Recombinant human granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol 2000; 28: 612–625
   PubMed Web of Science ®Google Scholar
• Rutella S., Rumi C., Sica S., Leone G. Recombinant human granulocyte colony-stimulating factor (rhG-CSF): effects on lymphocyte phenotype and function. J Interf Cytok Res 1999; 19: 989–994
   PubMed Web of Science ®Google Scholar
• Fegan C., Thomas H., Bailey-Wood R., Coleman S., Phillips S., Hoy T., Whittekar J. A. In vitro LAK activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 277–281
   PubMed Web of Science ®Google Scholar
• Aglietta M., Bertolini F., Carlo-Stella C., De Vincentiis A., Lanata L., Lemoli R. M., Olivieri A., Siesa S., Zanon P., Tura S. Ex vivo expansion of hematopoietic cells and their clinical use. Haematologica 2000; 85: 92–116
   Google Scholar
• Tsukamoto A., Sasaki D., Chen B. P., Hoffman R. Characterization and isolation of mobilized peripheral blood stem cells using a high-speed cell sorter. In Cell Therapy, G. Morstyn, W. Sheridan. Cambridge University Press, Cambridge 1996; 183–198
   Google Scholar
• Shpall E. J., LeMaistre C. F., Holland K., Ball E., Jones R. B., Saral R., Jacobs C., Heimfeld S., Berenson R., Champlin R. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 1997; 90: 4313–4320
   PubMed Web of Science ®Google Scholar
• Rutella S., Rumi C., Pierelli L., Morosetti R., Bonanno G., Sica S., Scambia G., Leone G. Recombinant human granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol 2000; 28: 612–625
   PubMed Web of Science ®Google Scholar
• Diviné M., Boutolleau D., Delfau-Larue M. H., Beaujean F., Jouault H., Reyes F., Kuentz M., Bensussan A., Farcet J. P., Boumsell L. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999; 105: 349–360
   PubMed Web of Science ®Google Scholar
• Tricot G., Gazitt Y., Leemhuis T., Jagannath S., Desikan K. R., Siegel D., Fassas A., Tindle S., Nelson J., Juttner C., Tsukamoto A., Hallagan J., Atkinson K., Reading C., Hoffman R., Barlogie B. Collection, tumor contamination and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma. Blood 1998; 91: 4489–4495
   PubMed Web of Science ®Google Scholar
• Vescio R., Schiller G., Stewart A. K., Ballester O., Noga S., Rugo H., Freytes C., Stadtmauer E., Tarantolo S., Sahebi F., Stiff P., Meharchard J., Schlossman R., Brown R., Tully H., Benyunes M., Jacobs C., Berenson R., Di Persio J., Anderson K., Berenson J. Multicenter phase III trial to evaluate CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 1999; 93: 1858–1868
   PubMed Web of Science ®Google Scholar
• Bomberger C., Singh-Jairam M., Rodey G., Guerriero A., Yeager A. M., Fleming W. H., Holland H. K., Waller E. K. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 1998; 91: 2588–2600
   PubMed Web of Science ®Google Scholar
• Goemer M., Wandt H., Schafer-Eckart K., Birkmann J., Denzel T., Gallmeier W. M. The use of CD34-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications. J Hematother Stem Cell Res 2000; 8: 387–391
   Google Scholar
• Voso M. T., Hohaus S., Moos M., Pforsich M., Cremer F. W., Schlenk R. F., Martin S., Hegenbart U., Goldschmidt H., Haas R. Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content. Br J Haematol 1999; 104: 382–391
   PubMed Web of Science ®Google Scholar
• Schiller G. J., Vescio R., Berenson J. Cytomegalovirus infection following transplantation of autologous CD34-selected progenitor cells [letter]. Blood 2000; 96: 1194
   PubMed Web of Science ®Google Scholar
• Peggs K. S., Ings S. J., Kottaridis P. D., Yong K., Williams C. D., Goldstone A. H., Mackinnon S. Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring [letter]. Blood 2000; 96: 369–370
   PubMed Web of Science ®Google Scholar
• Holmberg L. A., Boeckh M., Hooper H., Leisenring W., Rowley S., Heimfeld S., Press O., Maloney D. G., McSweeney P., Corey L., Maziarz R. T., Appelbaum F. R., Bensinger W. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999; 94: 4029–4035
   PubMed Web of Science ®Google Scholar
• Holmberg L. A., Bensinger W. I. Increased incidence of cytomegalovirus infection and disease after autologous CD34-selected PBSC transplantation [letter]. Blood 2000; 96: 370
   PubMed Web of Science ®Google Scholar
• Miyamoto T., Gondo H., Miyoshi Y., Shigematsu H., Minematsu T., Takenaka K., Tanimoto K., Horiuchi T., Asano Y., Inaba S., Minamishima Y., Niho Y. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1998; 100: 348–350
   PubMed Web of Science ®Google Scholar
• Einsele H., Ehninger G., Steidle M., Fischer I., Bihler S., Gerneth F., Vallbracht A., Schmidt H., Waller H. D., Muller C. A. Lymphocytepenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993; 82: 1672–1678
   PubMed Web of Science ®Google Scholar
• Friedman J., Lazarus H. M., Koc O. N. Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 2000; 26: 831–836
   PubMed Web of Science ®Google Scholar
• Lemoli R. M., Fortuna A., Motta M. R., Rizzi S., Giudice V., Nannetti A., Martinelli G., Cavo M., Amabile M., Mangianti S., Fogli M., Conte R., Tura S. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 1996; 87: 1625–1634
   PubMed Web of Science ®Google Scholar
• Laurenti L., Sorà F., Piccirillo N., Chiusolo P., Cicconi S., Rutella S., Serafini R., Garzia M. G., Leone G., Sica S. Immune reconstitution after autologous selected peripheral blood stem cell transplantation: comparison between two different CD34+ cell selection systems. Transfusion 2001, in press
   PubMed Web of Science ®Google Scholar
• Galy A., Rudraraju S., Baynes R., Klein J. Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplant 2000; 25: 1249–1255
   PubMed Web of Science ®Google Scholar
• Nachbaur D., Kropshofer G., Heitger A., Latzer K., Glassl H., Ludescher C., Nussbaumer W., Niederwieser D. Phenotypic and functional lymphocyte recovery after CD34-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematoth Stem Cell Res 2000; 9: 727–736
   PubMedGoogle Scholar
• Nelson B. H., Willerford D. M. Biology of the interleukin-2 receptor. Adv Immunol 1998; 70: 1–81
   PubMed Web of Science ®Google Scholar
• Hebib N. C., Deas O., Rouleau M., Durrbach A., Charpentier B., Beaujean F., Vernant J. P., Senik A. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T cell profiles. Blood 1999; 94: 1803–1813
   PubMed Web of Science ®Google Scholar
• Singh R. K., Varney M. L., Buyukberber S., Ino K., Ageitos A. G., Reed E., Tarantolo S., Talmadge J. E. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation. Cancer Res 1999; 59: 3107–3111
   PubMed Web of Science ®Google Scholar
• Rutella S., Rumi C., Pierelli L., Bonanno G., Mariotti A., Sorà F., Chiusolo P., Scambia G., Sica S., Leone G. Immunological reconstitution after autologous progenitor cell transplantation: the γ-chain signaling cytokines IL-2 and IL-15 counteract T-cell spontaneous apoptosis and enhance antigen responsiveness [abstract]. Blood 2000; 96(1826)425
   Google Scholar
• Blaise D., Attal M., Reiffers J., Michallet M., Bellanger C., Pico J. L., Stoppa A. M., Payen C., Mark G., Bonabdallah R., Sotto J. J., Rossi J. F., Brandley M., Hercend T., Maraninchi D. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. Eur Cytokine Netw 2000; 11: 91–98
   PubMed Web of Science ®Google Scholar
• Blaise D., Attal M., Pico J. L., Reiffers J., Stoppa A. M., Bellanger C., Molina L., Nedellec G., Vernant J. P., Legros M., Gabus R., Huguet F., Brandely M., Hercend T., Olive D., Maraninchi D. The use of a sequential high dose recombinant interleukin-2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission. Leukemia Lymphoma 1997; 25: 469–478
   PubMed Web of Science ®Google Scholar
• Katsanis E., Xu Z., Panoskaltsis-Mortari A., Weisdorf D. J., Widmer M. B., Blazar B. R. IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice. Transplantation 1996; 62: 872–875
   PubMed Web of Science ®Google Scholar
• Fehniger T. A., Caligiuri M. A. Interleukin-15: biology and relevance to human disease. Blood 2001; 97: 14–32
   PubMed Web of Science ®Google Scholar
• Toubert A., Clave E., Talvensaari K., Douay C., Charron D. New tools in assessing immune reconstitution after hematopoietic stem cell transplantation. Vox Sang 2000; 78((suppl 2))29–31
   PubMedGoogle Scholar
• Gorsky J., Yassai M., Zhu X., Kissella B., Keever C., Flomenberg N. Circulating T-cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol 1994; 152: 5109–5113
   PubMed Web of Science ®Google Scholar
• Verfuerth S., Peggs K., Vyas P., Barnett L., O'Reilly R., Mackinnon S. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood 2000; 95: 3990–3995
   PubMed Web of Science ®Google Scholar
• Sica S., Sorà F., Chiusolo P., Laurenti L., Cattani P., Giordano G., Piccirillo N., Leone G. Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation [letter]. Bone Marrow Transplant 2000; 26: 587–588
   PubMed Web of Science ®Google Scholar